Physician Practice Patterns Related to the Key Points of the K/DOQI Guidelines29,30
| Guideline | Qualitative Interview (n = 10) | Quantitative Exit Survey (n = 10) |
|---|---|---|
| Use of GFR to diagnose CKD | 1 | N/A |
| Check for microalbumin | N/A | 9 |
| Control BP to <130/80 | 10 | 10 |
| Use ACE/ARB early | 8 | N/A |
| Treat cholesterol | N/A | 8 |
| HDL >40 | ||
| LDL <100 | ||
| Use erythropoietin for anemia | 2 | N/A |
| Keep hemoglobin >11 | 1 | 1 |
| Check calcium, phosphorous, and PTH for bone disease | 2 | 8 |
| Refer to nephrologist for GFR <30 | 0 | N/A |
K/DOQI, Kidney Disease Outcomes Quality Initiative; GFR, glomerular filtration rate; CKD, chronic kidney disease; BP, blood pressure; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; HDL, high-density lipoprotein; LDL, low-density lipoprotein; PTH, parathyroid hormone.